AML’s arrangement with Sun Pharma was unique because, typically in a pharma business, the distributor is a third party, who buys the stock from the manufacturer and sells it to retailers over a margin fee.from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2DkTSNW
via IFTTT
0 comments:
Post a Comment